197 related articles for article (PubMed ID: 25344216)
21. HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.
Hristov AC; Cope L; Di Cello F; Reyes MD; Singh M; Hillion JA; Belton A; Joseph B; Schuldenfrei A; Iacobuzio-Donahue CA; Maitra A; Resar LM
Mod Pathol; 2010 Jan; 23(1):98-104. PubMed ID: 19820691
[TBL] [Abstract][Full Text] [Related]
22. Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis.
Wang F; Liu Y; Chen Y
Biomed Pharmacother; 2016 Dec; 84():1595-1600. PubMed ID: 27829547
[TBL] [Abstract][Full Text] [Related]
23. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis.
Wang T; Liu X; Tian Q; Liang T; Chang P
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485
[TBL] [Abstract][Full Text] [Related]
24. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
[TBL] [Abstract][Full Text] [Related]
25. HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
Greco M; Arcidiacono B; Chiefari E; Vitagliano T; Ciriaco AG; Brunetti FS; Cuda G; Brunetti A
Anticancer Res; 2018 Feb; 38(2):771-778. PubMed ID: 29374701
[TBL] [Abstract][Full Text] [Related]
26. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
29. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
30. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
Lin L; Gu ZT; Chen WH; Cao KJ
Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
[TBL] [Abstract][Full Text] [Related]
32. Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers.
He Y; Chen X; Liu H; Xiao H; Kwapong WR; Mei J
Cancer Biomark; 2015; 15(5):645-51. PubMed ID: 26406953
[TBL] [Abstract][Full Text] [Related]
33. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
[TBL] [Abstract][Full Text] [Related]
35. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
36. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
38. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.
Pang B; Fan H; Zhang IY; Liu B; Feng B; Meng L; Zhang R; Sadeghi S; Guo H; Pang Q
J Neurooncol; 2012 Feb; 106(3):543-9. PubMed ID: 21984063
[TBL] [Abstract][Full Text] [Related]
39. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis.
Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J
Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
Tian Y; Feng Y
Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
